Clinical trials
Observational Intermittent Claudication trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Unknown status | 15 |
| Recruiting | 4 |
| Not yet recruiting | 3 |
| Terminated | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Angers | 8 |
| Copenhagen University Hospital at Herlev | 5 |
| Norwegian University of Science and Technology | 2 |
| Ulrich Rother | 2 |
| Yonsei University | 2 |
| Angiodynamics, Inc. | 1 |
| C. R. Bard | 1 |
| Cardiology Research UBC | 1 |
| Chinese University of Hong Kong | 1 |
| Clinical Centre of Serbia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intermittent Claudication | 57 |
| Peripheral Arterial Disease | 37 |
| Chronic Limb-Threatening Ischemia | 13 |
| Atherosclerosis | 9 |
| Peripheral Vascular Diseases | 9 |
| Cardiovascular Diseases | 3 |
| Arterial Occlusive Diseases | 2 |
| Inflammation | 2 |
| Lymphoma, Follicular | 2 |
| Spinal Stenosis | 2 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.